We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

InvestoGain Australia

Celebrating 20 Years in Business

Thank you for being part of our development since September 2001. With your ongoing support we look forward to many exciting developments ahead.


Any AUS or NZ company


Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z



Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:


Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names


Shareholder links

Our website ranking of API: rating 5
(5 out of 5)



Boardroom Pty Ltd, Level 12, 225 George Street, Sydney NSW 2000

Tel : +61 2 9290 9600 or 1300 737 760
Fax : +61 2 9279 0664 or 1300 653 459
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000API4
Address: Level 5 250 Camberwell Road Camberwell VIC 3124 Australia
Tel:  (+61 3) 8855 3000 Fax: (+61 3) 8855 3402

Date first listed: 16/06/1997
Company Secretary: Anne Mustow
Sector: Health Care Equipment & Services Industry Group: XHJ
Activities: Wholesale distributor of pharmaceutical and allied products and retail support services to pharmacists

News & Events

Expand this box to read and print

API has today announced that in preparation for the release of its half year results, it will incur an asset impairment charge of $131 million. Notwithstanding this non-cash charge, the underlying business performance is strong, with a net profit after tax of $16.2 million, subject to final auditor review, for the six months ended 28 February 2014 (up from $12.6 million for the prior comparable period).


The suspension of trading in the securities of Australian Pharmaceutical Industries Limited (the "Company") will be lifted immediately, following the Company's announcement in relation to the carrying value of its assets. Security Code: API


The securities of Australian Pharmaceutical Industries Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement regarding the carrying value of its assets. Security Code: API


shares reinstated to quotation


company advises that the Australian Securities & Investments Commission (ASIC) had granted the company an extension to lodge its Final Accounts on Monday 21 August 2006 - the Australian Stock Exchange (ASX) has advised that API shares will recommence trading the day following the Final Accounts being lodged with ASIC and the ASX


appoints new CEO, releases preliminary final report and Results for Year Ended 30 April 2006 and also a FY06 Results Presentation - the company has lost $17m but can't explain how or where


company advises that on Monday 14 August 2006 it will be releasing its full-year financial results for the year ended 30 April 2006. There will be a teleconference briefing held at 1 p.m. on 14 August. The teleconference can be accessed by calling: Dial in # 1800 097 137 Confirmation Code 5065872


company advises that the Australian Securities & Investments Commission has granted the company an extension to enable the company to lodge its financial results and report for financial year 2006 on or by 14 August 2006


the company today advised that while it had made progress on resolving a number of the issues delaying the release of its financial results, there are still some outstanding items that require further attention


shares suspended from quotation pending release of an announcement

OFX Transferring Money Internationally to Free


Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.


Company Updates

Post your comments here

Please read our Terms before posting comments.
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...



    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    14/12/2020Jennifer MacDonald25,000$1.305$32,625
    24/04/2020Mark Smith40,000$1.039$41,550
    23/04/2020Jennifer MacDonald15,000$1.010$15,150
    03/02/2020Mark Smith30,000$1.299$38,981
    20/12/2019Mark Smith40,000$1.320$52,800

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    Kenneth Gunderson-BriggsChairman, Independent Director06/05/2014
    Richard VincentManaging Director, CEO15/02/2017
    Janine AllisIndependent Director23/10/2020
    Clive StiffIndependent Director04/12/2020
    Lee AusburnIndependent Director07/10/2008
    George TambassisNon Exec Director07/06/2021
    Jennifer MacDonaldNon Exec Director09/11/2017
    Peter SanguinettiGeneral Counsel30/11/2007

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    Mark SmithNon Exec Chairman, Independent Director06/09/201704/09/2020
    Robert MillnerNon Exec Director12/05/200009/07/2020
    Gerard MastersIndependent Director07/09/201022/01/2020
    Peter RobinsonNon Exec Chairman05/05/200024/01/2018
    Stephen RocheManaging Director, CEO14/08/200615/02/2017
    Carol HolleyIndependent Director19/12/200625/01/2017
    Michael WooldridgeIndependent Director01/02/200631/12/2014
    Graeme FalletCFO24/08/200919/12/2014
    Miles HamptonIndependent Director07/08/200730/01/2014
    Barry FrostDeputy Chairman20/09/199331/07/2008
    David FairfullNon Exec Director05/05/200016/08/2007
    John MurphyNon Exec Director07/10/200407/08/2007
    Gregory RoberstonAlternate Director07/10/200407/08/2007
    Michael SmithNon Exec Director25/09/198121/08/2006
    Jeffrey SherExecutive07/10/200414/08/2006
    Graeme HerringNon Exec Director01/04/199708/06/2004
    Fritz HorlacherNon Exec Director21/04/2004
    Peter WrightNon Exec Director21/04/2004
    David YoungManaging Director15/11/200008/01/2004
    Frank ConroyChairman29/10/199908/07/2003
    Verilyn FitzgeraldNon Exec Director01/09/199708/07/2003

    Date of first appointment, title may have changed.